Ronald Allen Louks is COO at NantHealth, Inc. (NH). They have made 16 open-market trades across 1 company since 2017, most recently 2021-09-13.
CIK 0001706849
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NH | 225,857 | $305K |
Shares reported on the most recent Form 4, priced at the 2021-09-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NH | SELL | 2021-09-10 | 2021-09-14 | $2.00 | $33K | -6.0% | -4.9% | -44.8% |
| NH | SELL | 2021-09-03 | 2021-09-09 | $2.29 | $52K | -12.5% | -14.5% | -45.0% |
| NH | SELL | 2021-03-12 | 2021-03-16 | $3.71 | $297K | -12.5% | -27.7% | -23.0% |
| NH | SELL | 2018-10-06 | 2018-10-09 | $1.42 | $9K | -3.5% | +11.3% | -50.1% |
| NH | SELL | 2018-09-06 | 2018-09-07 | $1.89 | $12K | -7.1% | -23.0% | -56.0% |
| NH | SELL | 2018-08-06 | 2018-08-07 | $3.15 | $20K | -26.5% | -40.4% | -50.5% |
| NH | SELL | 2018-07-06 | 2018-07-10 | $3.54 | $20K | -7.5% | -7.8% | -57.5% |
| NH | SELL | 2018-06-06 | 2018-06-07 | $3.49 | $20K | -10.0% | -4.6% | -44.4% |
| NH | SELL | 2018-05-06 | 2018-05-08 | $3.41 | $24K | -6.3% | -0.3% | -10.3% |
| NH | SELL | 2018-04-06 | 2018-04-10 | $3.04 | $21K | +3.4% | -3.8% | +4.7% |
| NH | SELL | 2018-03-06 | 2018-03-08 | $3.56 | $25K | -18.1% | -16.5% | -5.7% |
| NH | SELL | 2018-02-06 | 2018-02-07 | $3.02 | $20K | -1.9% | +15.8% | +11.0% |
| NH | SELL | 2018-01-08 | 2018-01-09 | $3.52 | $22K | -1.8% | -24.6% | -20.8% |
| NH | SELL | 2017-12-06 | 2017-12-07 | $3.03 | $16K | +7.0% | +19.5% | +23.2% |
| NH | SELL | 2017-11-06 | 2017-11-08 | $3.39 | $23K | +2.6% | -9.7% | -11.2% |
| NH | SELL | 2017-10-06 | 2017-10-10 | $4.28 | $230K | -4.7% | -13.6% | -10.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.